Noa Therapeutics is a preclinical biotech company pioneering the development of homeostatic modulating small molecules, targeting barrier resolution, to effectively modify pathogenic drivers of inflammatory diseases. Adopting a systems biology and computer-assisted discovery approach, Noa is establishing a novel small molecule platform for the tailored treatment of immune diseases involving barrier dysfunction to address unmet needs in over $100B of inflammatory disease markets.

Noa Therapeutics logo



Event details

Date: June 3 - 6, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


42 in total